Guided Therapeutics, Inc. Stock
Stocks
GTHP
US40171F5017
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2290 USD | -.--% |
|
-16.73% | -57.59% |
| 07-14 | Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation | CI |
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| Market Cap | 25.58M 22.46M 20.94M 19.25M 36.08M 2.45B 36.69M 247M 97.05M 1.21B 96.03M 93.96M 4.19B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 28.46M 24.99M 23.3M 21.42M 40.14M 2.73B 40.82M 275M 108M 1.35B 107M 105M 4.66B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -16.73% | ||
| Current month | -4.58% | ||
| 1 month | -4.58% | ||
| 3 months | +14.50% | ||
| 6 months | -41.28% | ||
| Current year | -57.59% |
| 1 week | 0.2 | 0.27 | |
| 1 month | 0.2 | 0.32 | |
| Current year | 0.17 | 0.54 | |
| 1 year | 0.12 | 0.54 | |
| 3 years | 0.06 | 0.54 | |
| 5 years | 0.06 | 0.78 | |
| 10 years | 0.02 | 3,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/10/26 A | Others | Director | 10 | 0.9747% | ||
| 3/10/26 A | Free | Chairman | 110,000 | 0.1316% | ||
| 3/10/26 A | Free | Director | 110,000 | 0.1316% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -16.73% | -8.40% | +52.67% | 25.58M | ||
| +3.02% | +9.54% | +20.51% | +2.93% | 208B | ||
| +1.30% | -1.02% | -3.13% | -22.02% | 138B | ||
| +1.39% | +2.44% | -27.04% | +11.82% | 126B | ||
| +1.21% | +5.23% | -56.60% | -12.50% | 67.64B | ||
| +0.77% | -1.55% | +4.60% | +1.22% | 47.81B | ||
| +1.01% | +1.61% | -25.12% | -32.86% | 45.03B | ||
| +1.92% | +7.89% | +16.94% | +10.96% | 38.94B | ||
| +3.42% | +7.37% | +26.72% | +34.60% | 36.45B | ||
| +2.90% | +5.21% | -24.06% | -5.66% | 29.29B | ||
| Average | +1.69% | +0.93% | -7.56% | +4.11% | 73.73B | |
| Weighted average by Cap. | +1.94% | +1.40% | -4.59% | -2.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.15K 5.73K 5.27K 9.87K 671K 10.04K 67.71K 26.56K 331K 26.28K 25.71K 1.15M | 767K 673K 628K 577K 1.08M 73.51M 1.1M 7.42M 2.91M 36.31M 2.88M 2.82M 126M |
| Net income | -2.42M -2.12M -1.98M -1.82M -3.41M -232M -3.47M -23.38M -9.17M -114M -9.07M -8.88M -396M | -3.2M -2.81M -2.62M -2.41M -4.51M -306M -4.58M -30.91M -12.12M -151M -12M -11.74M -523M |
| Net Debt | 1.77M 1.55M 1.45M 1.33M 2.5M 170M 2.54M 17.13M 6.72M 83.84M 6.65M 6.5M 290M | 2.88M 2.53M 2.35M 2.16M 4.06M 276M 4.12M 27.82M 10.91M 136M 10.8M 10.56M 471M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | $0.2440 | -7.92% | 3,050 |
| 27/07/26 | $0.2650 | +1.92% | 6,091 |
| 23/07/26 | $0.2600 | -3.70% | 5,100 |
| 22/07/26 | $0.2700 | -0.47% | 310 |
| 21/07/26 | $0.2713 | -1.35% | 5,500 |
- Stock Market
- Stocks
- GTHP Stock
Select your edition
All financial news and data tailored to specific country editions
















